Nanoparticle biosensors for cardiovascular disease detection.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cardiovascular Diagnostics

Background:

• Early detection of cardiovascular diseases (CVDs) is vital for patient survival and health outcomes.
• Biomarkers like cardiac Troponin-I (cTnI) and NT-proBNP indicate heart muscle injury, such as in acute myocardial infarction (AMI).
• Current diagnostic methods require timely and accurate detection of these biomarkers.

Purpose of the Study:

• To review the application of various nanoparticles in developing sensitive and specific biosensors for CVD biomarker detection.
• To highlight the advantages of nanomaterials in enhancing biosensor performance for early CVD diagnosis.

Main Methods:

• Discussion of optical and electrochemical biosensors utilizing nanoparticles.
• Exploration of how nanomaterials modify sensor surfaces for improved capture molecule immobilization.
• Focus on inorganic nanoparticles for their response intensification, functionalization, biocompatibility, and stability.

Main Results:

• Nanoparticle-modified biosensors demonstrate successful detection of CVD biomarkers.
• Nanomaterials enhance the immobilization of antibodies and aptamers on sensor surfaces.
• Inorganic nanoparticles offer significant advantages in biosensor performance.

Conclusions:

• Nanoparticle-based biosensors are effective tools for the sensitive and specific detection of CVD biomarkers.
• These biosensors facilitate early CVD detection and rapid intervention, potentially reducing morbidity and mortality.
• The use of nanomaterials in biosensor technology represents a significant advancement in cardiovascular diagnostics.